SPC350
Icosapentetýl
Status:
VeittApplication date:
15.9.2021Application published:
15.10.2021Grant published:
15.2.2025
Max expiry date:
14.6.2035Medicine name:
VazkepaMedicine for children:
No
Timeline
Today
15.9.2021Application
15.10.2021Publication
15.2.2025Registration
14.6.2035Expires
Marketing license
IS authorization number:
EU/1/20/1524/001-002Date:
30.3.2021
Foreign authorization number:
EU/1/20/1524Date:
26.3.2021
Owner
Name:
Amarin Pharmaceuticals Ireland LimitedAddress:
2 Pembroke House Upper Pembroke Street 28-32, Dublin 2 IE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2443246
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 05.01.2025